Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:EUCRUOTCMKTS:GTAXOTCMKTS:JFKKUOTCMKTS:PAIR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEUCRUEucrates Biomedical Acquisition$10.02+0.1%$10.02$9.76▼$10.66N/AN/A1,921 shs21,500 shsGTAX(GTAX)$0.00$0.00▼$0.00N/AN/AN/AN/AJFKKU8i Enterprises Acquisition$10.80-7.2%$10.80$9.72▼$26.99N/AN/A3,516 shs900 shsPAIR(PAIR)$0.00$0.00▼$0.00N/AN/AN/AN/AA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEUCRUEucrates Biomedical Acquisition0.00%0.00%0.00%0.00%0.00%JFKKU8i Enterprises Acquisition0.00%0.00%0.00%0.00%0.00%PAIR(PAIR)0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEUCRUEucrates Biomedical AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AGTAX(GTAX)N/AN/AN/AN/AN/AN/AN/AN/AJFKKU8i Enterprises AcquisitionN/AN/AN/AN/AN/AN/AN/AN/APAIR(PAIR)N/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEUCRUEucrates Biomedical Acquisition 0.00N/AN/AN/AGTAX(GTAX) 0.00N/AN/AN/AJFKKU8i Enterprises Acquisition 0.00N/AN/AN/APAIR(PAIR) 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEUCRUEucrates Biomedical AcquisitionN/AN/AN/AN/AN/AN/AGTAX(GTAX)N/AN/AN/AN/AN/AN/AJFKKU8i Enterprises AcquisitionN/AN/AN/AN/AN/AN/APAIR(PAIR)N/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEUCRUEucrates Biomedical AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/AGTAX(GTAX)N/AN/A0.00N/AN/AN/AN/AN/AN/AJFKKU8i Enterprises AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/APAIR(PAIR)N/AN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEUCRUEucrates Biomedical AcquisitionN/AN/AN/AN/AN/AGTAX(GTAX)N/AN/AN/AN/AN/AJFKKU8i Enterprises AcquisitionN/AN/AN/AN/AN/APAIR(PAIR)N/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEUCRUEucrates Biomedical AcquisitionN/AGTAX(GTAX)N/AJFKKU8i Enterprises AcquisitionN/APAIR(PAIR)N/AInsider OwnershipCompanyInsider OwnershipEUCRUEucrates Biomedical AcquisitionN/AGTAX(GTAX)N/AJFKKU8i Enterprises AcquisitionN/APAIR(PAIR)N/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEUCRUEucrates Biomedical Acquisition4N/AN/ANot OptionableGTAX(GTAX)N/AN/AN/ANot OptionableJFKKU8i Enterprises AcquisitionN/AN/AN/ANot OptionablePAIR(PAIR)N/AN/AN/ANot OptionableEUCRU, GTAX, PAIR, and JFKKU HeadlinesRecent News About These CompaniesNo headlines for this company have been tracked by MarketBeat.comEUCRU, GTAX, PAIR, and JFKKU Company DescriptionsEucrates Biomedical Acquisition OTCMKTS:EUCRU$10.02 +0.01 (+0.10%) As of 04/26/2023Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.(GTAX) OTCMKTS:GTAXGilman Ciocia, Inc. provides federal, state and local taxes preparation services to individuals, predominantly in the middle and upper income tax brackets, accounting services to small and midsize companies and financial planning services, including securities brokerage, investment management services, insurance and financing services. As of June 30, 2012, the Company had 27 offices operating in three states (New York, New Jersey, and Florida). The Company also provides financial planning services through approximately 33 independently owned and operated offices in 10 states. The Company's financial planning clients are introduced to the Company through the Company's tax return preparation services, accounting services and educational workshops. In October 2013, National Holdings Corporation announced that it has the completed the merger with Gilman Ciocia, Inc.8i Enterprises Acquisition OTCMKTS:JFKKU$10.80 -0.84 (-7.22%) As of 09/30/20208i Enterprises Acquisition Corp. intends to enter into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination. The company was founded in 2017 and is based in Singapore.(PAIR) OTCMKTS:PAIR More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/12 - 05/16 Retail Investors Are Betting Big on Rocket Lab—Should You Too? Meta's 5 Key Pillars for AI Growth—Zuckerberg's Bold Vision Taiwan Semiconductor Stock Is The Gift That Keeps on Giving GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine Alibaba's Earnings Just Changed Everything for the Stock Plug Power: Is Q1 Noise An Opportunity for Accumulation? Cisco Stock Eyes New Highs in 2025 on AI, Earnings, Upgrades Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.